Home/Filings/4/0001779092-25-000007
4//SEC Filing

Duraibabu Prathyusha 4

Accession 0001779092-25-000007

CIK 0001001233other

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 4:07 PM ET

Size

6.3 KB

Accession

0001779092-25-000007

Insider Transaction Report

Form 4
Period: 2025-11-24
Duraibabu Prathyusha
SVP, CHIEF FINANCIAL OFFICER
Transactions
  • Tax Payment

    Common Stock

    2025-11-24$0.42/sh2,544$1,060696,718 total
Footnotes (2)
  • [F1]Represents shares underlying the portion of a restricted stock unit ("RSU") grant that vested on November 24, 2025, which were surrendered by the Reporting Person solely for mandatory tax withholding purposes using the Issuer's closing stock price on November 24, 2025 of $0.4166/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP"). This required tax withholding transaction is deemed to constitute a disposition of these shares to the Issuer for reporting purposes and does not represent a discretionary trade by the Reporting Person in the open market or otherwise.
  • [F2]Includes: (a) 2,466 shares resulting from the November 24, 2025 vesting installment of the Reporting Person's February 24, 2023 RSU grant, and the remaining 5,010 shares will vest on February 24, 2026, (b) 89,063 shares subject to Reporting Person's January 22, 2024 RSU grant that will vest in successive equal quarterly installments through January 22, 2026 and (c) 120,000 shares subject to Reporting Person's February 25, 2025 RSU grant that will vest as to one-fourth (1/4) of the shares on February 25, 2026, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.

Issuer

SANGAMO THERAPEUTICS, INC

CIK 0001001233

Entity typeother

Related Parties

1
  • filerCIK 0001779092

Filing Metadata

Form type
4
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:07 PM ET
Size
6.3 KB